EarlyTect BCD test : Promis Diagnostics gets FDA breakthrough designation

Promis Diagnostics has secured breakthrough device designation for its non-invasive EarlyTect BCD test from the US Food and Drug Administration (FDA) as a urine-based diagnosis ... Read More